Brainify.AI
Revolutionizing Psychiatry Treatment with AI-Driven Precision Psychiatry: Transforming Patient Outcome and Clinical Trials
- Stage Product In Market
- Industry Biotechnology
- Location New York, NY, USA
- Currency USD
- Founded February 2021
- Employees 10
- Incorporation Type C-corp
- Website brainify.ai
Company Summary
Brainify.AI has developed a precision psychiatry platform that uses AI to analyze EEG (brain waves), predicting treatment outcomes before treatment even begins. This boosts drug efficacy and increases clinical trial success. The current psychiatric treatments rely on a trial-and-error approach. Our business model involves licensing our AI technology for patient care and late-stage clinical trials.
Team
-
COO & co-founder
Entrepreneur with 20 years of experience in tech. He sold a previous startup to Zurich Insurance. HBS PLDA 2024
-
CEO & co-founderA neuroscientist from Harvard with 10+ years of experience in the tech industry.
Advisors
-
Diego A. PizzagalliUnconfirmed
Conor ListonUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.